We strive to transform current organ transplant science, technologies and techniques to provide more reliable, effective and life saving solutions for humanity.
VirTech Bio develops innovative therapies for organ and tissue preservation, ex vivo organ management and biomarker discovery using a technology platform combining machine perfusion (MP) with a new hemoglobin-based oxygen carrier (HBOC).
VirTech Bio has developed a novel approach for oxygen delivery while managing organs and tissue outside the body.
How It Works
VirTech oxygen delivery technology improves organ quality and extends viability
Current transplant protocols lead to damaged organs and suboptimal outcomes